Some common side effects of GLP-1s include loss of appetite, nausea, vomiting and diarrhea, according to the Cleveland Clinic
Discontinuation is typically driven by lack of perceived benefit, cost considerations, or completion of a defined protocol cycle rather than safety concerns
Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control
The role of alpha lipoic acid in female and male infertility: A systematic review
Medicare does cover GLP-1s today, but only when prescribed for an underlying condition, not just for weight loss
These differing targets may produce different metabolic and body composition outcomes across populations